Addex Therapeutics to Release Q1 2024 Financial Results and

Geneva, Switzerland, May 31, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio...

Related Keywords

Geneva ,Genè ,Switzerland ,United States ,American ,Swiss ,Mikhail Kalinichev ,Mike Sinclair ,Tim Dyer ,Swiss Exchange ,Janssen Pharmaceuticals Inc ,Nasdaq ,Translational Science ,Addex Therapeutics ,Conference Call ,Participant Dial In ,American Depositary Shares ,